CIP2A antibody

Synonyms:Cancerous inhibitor of PP2A antibody, CIP2A antibody, KIAA1524 antibody, p90 antibody, p90 autoantigen antibody, Protein CIP2A antibody
Catalogue No.:FNab10841Reactivity:Human, Rat
Host:MouseTested Application:ELISA, WB
Clonality:monoclonalIsotype:IgG1
  • SPECIFICATIONS
Product Name
CIP2A antibody
Catalogue No.
FNab10841
Size
100μg
Form
liquid
Purification
protein A+G purified
Purity
≥95% as determined by SDS-PAGE
Clonality
monoclonal
Isotype
IgG1
Clone ID
9H8
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
KIAA1524
Alternative Names
Cancerous inhibitor of PP2A antibody, CIP2A antibody, KIAA1524 antibody, p90 antibody, p90 autoantigen antibody, Protein CIP2A antibody
UniProt ID
Q8TCG1
Observed MW
102 kDa
Application
Tested Applications
ELISA, WB
Recommended dilution
WB: 1:1000 - 1:10000
Validated Images
Various lysates were subjected to SDS PAGE followed by western blot with FNab10841(CIP2A antibody) at dilution of 1:5000
Background
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.